Skip to main content

Table 2 Paired analysis of tumor cells before and after NACT

From: Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

  Tumor cells after NACT  
Tumor cells before NACT Negative Positive Total
Total 96 22 (19 %) 118
 DTC-negative 73 14 87
 DTC-positive 23 8 31 (26 %)
Total 82 10 (11 %) 92
 CTC-negative 58 9 67
 CTC-positive 24 1 25 (27 %)
Total 39 9 (19 %) 48
 slCTC-negative 18 1 19
 slCTc-positive 21 8 29 (60 %)
  1. CTC circulating tumor cell, DTC disseminated tumor cell, NACT neoadjuvant chemotherapy